Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Movers & Shakers
Katten Muchin Rosenman LLP has announced that Jeffrey Alan Hovden has joined the firm as a New York-based partner in its Intellectual Property Practice. Hovden, who concentrates his practice in intellectual property litigation, was previously a partner in the New York office of Frommer Lawrence & Haug LLP.
Hovden's practice focuses on litigating patent infringement and invalidity actions on most of the world's top-selling prescription drugs, for both generic and name-brand clients. He also litigates pharmaceutical patent cases under the Hatch-Waxman Act. Hovden has experience advising clients on drug-approval provisions under the Food, Drug and Cosmetic Act and their attendant regulations. He provides infringement, validity and due-diligence opinions, and counsels biotechnology clients on licensing matters. Hovden has also worked in the area of copyrights, particularly of functional works.
The Dallas trial law firm Rose'Walker, L.L.P., has announced the addition of intellectual property attorney John Pinkerton as a partner.
Pinkerton's intellectual property practice focuses on patent litigation, patent and technology license agreements, and opinions of counsel on issues of patent infringement, validity, and enforceability. His expertise also includes cases involving trademark and copyright infringement and trade secret misappropriation, as well as trademark registrations and trademark opposition and cancellation proceedings.
“John is a seasoned intellectual property attorney and a great addition to the firm,” says Rose'Walker Administrative Partner Mike Richardson. “His lengthy career in IP law adds to our expertise and increases the courtroom threat we present in the ever-expanding number of IP cases we handle.”
Pinkerton joins Rose'Walker from Gardere Wynne Sewell LLP, where he was a partner in the firm's intellectual property section. He previously handled intellectual property matters while practicing with Hunton & Williams LLP and Jones, Day, Reavis & Pogue in Dallas, and also served in the U.S. Army Judge Advocate General's Corps.
Hovden's practice focuses on litigating patent infringement and invalidity actions on most of the world's top-selling prescription drugs, for both generic and name-brand clients. He also litigates pharmaceutical patent cases under the Hatch-Waxman Act. Hovden has experience advising clients on drug-approval provisions under the Food, Drug and Cosmetic Act and their attendant regulations. He provides infringement, validity and due-diligence opinions, and counsels biotechnology clients on licensing matters. Hovden has also worked in the area of copyrights, particularly of functional works.
The Dallas trial law firm Rose'Walker, L.L.P., has announced the addition of intellectual property attorney John Pinkerton as a partner.
Pinkerton's intellectual property practice focuses on patent litigation, patent and technology license agreements, and opinions of counsel on issues of patent infringement, validity, and enforceability. His expertise also includes cases involving trademark and copyright infringement and trade secret misappropriation, as well as trademark registrations and trademark opposition and cancellation proceedings.
“John is a seasoned intellectual property attorney and a great addition to the firm,” says Rose'Walker Administrative Partner Mike Richardson. “His lengthy career in IP law adds to our expertise and increases the courtroom threat we present in the ever-expanding number of IP cases we handle.”
Pinkerton joins Rose'Walker from
Major Differences In UK, U.S. Copyright Laws
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
The Article 8 Opt In
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
Strategy vs. Tactics: Two Sides of a Difficult Coin
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
Legal Possession: What Does It Mean?
Possession of real property is a matter of physical fact. Having the right or legal entitlement to possession is not "possession," possession is "the fact of having or holding property in one's power." That power means having physical dominion and control over the property.
The Anti-Assignment Override Provisions
UCC Sections 9406(d) and 9408(a) are one of the most powerful, yet least understood, sections of the Uniform Commercial Code. On their face, they appear to override anti-assignment provisions in agreements that would limit the grant of a security interest. But do these sections really work?